Ares Commercial Real Estate Corp.

  • Market Cap: Micro Cap
  • Industry: Realty
  • ISIN: US04013V1089
USD
5.15
-0.15 (-2.83%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

398.62 k

Shareholding (Mar 2025)

FII

3.47%

Held by 43 FIIs

DII

72.02%

Held by 27 DIIs

Promoter

0.00%

How big is Ares Commercial Real Estate Corp.?

22-Jun-2025

As of Jun 18, Ares Commercial Real Estate Corp. has a market capitalization of 264.58 million and reported net sales of 123.40 million, with a net profit loss of 13.31 million. Shareholder's funds are 540.13 million, and total assets amount to 1,751.21 million.

As of Jun 18, Ares Commercial Real Estate Corp. has a market capitalization of 264.58 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 123.40 million for the latest four quarters. However, it also experienced a net profit loss of 13.31 million during the same period.<BR><BR>As of Dec 24, the reporting period for the balance sheet shows shareholder's funds of 540.13 million and total assets amounting to 1,751.21 million.

Read More

What does Ares Commercial Real Estate Corp. do?

22-Jun-2025

Ares Commercial Real Estate Corporation is a specialty finance company that originates and invests in commercial real estate loans. It has a market cap of approximately $264.58 million and reported net sales of $33 million and a net profit of $9 million for the most recent quarter.

Overview:<BR>Ares Commercial Real Estate Corporation is a specialty finance company engaged in originating and investing in commercial real estate loans and related investments, operating within the Realty industry and classified as a Micro Cap.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 33 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 9 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 264.58 Million (Micro Cap)<BR><BR>Key Metrics:<BR>Dividend Yield: 1,537.73% <BR>Debt Equity: -999,999.00 <BR>Return on Equity: -2.46% <BR>Price to Book: 0.49<BR><BR>Contact Details:<BR>Address: 245 Park Ave Fl 42, NEW YORK NY : 10167-0002 <BR>Tel: 1 212 5153400 <BR>Fax: 1 312 2527501 <BR>Website: http://www.arescre.com/

Read More

Who are in the management team of Ares Commercial Real Estate Corp.?

22-Jun-2025

As of March 2022, the management team of Ares Commercial Real Estate Corp. includes Chairman William Benjamin, Lead Independent Director Caroline Blakely, and Directors Michael Arougheti, Rand April, William Browning, and Edmond Moriarty, who oversee the company's strategic direction and governance.

As of March 2022, the management team of Ares Commercial Real Estate Corp. includes the following individuals:<BR><BR>- Mr. William Benjamin, Chairman of the Board<BR>- Ms. Caroline Blakely, Lead Independent Director<BR>- Mr. Michael Arougheti, Director<BR>- Mr. Rand April, Independent Director<BR>- Mr. William Browning, Independent Director<BR>- Mr. Edmond Moriarty, Independent Director<BR><BR>This team is responsible for overseeing the company's strategic direction and governance.

Read More

Is Ares Commercial Real Estate Corp. overvalued or undervalued?

20-Sep-2025

As of February 22, 2024, Ares Commercial Real Estate Corp. is considered risky and overvalued due to its low Price to Book Value of 0.49, high EV to EBITDA ratio of 1.49, negative ROE of -2.46%, and significant underperformance with a stock return of -36.95% over the past year compared to the S&P 500's 17.14%.

As of 22 February 2024, the valuation grade for Ares Commercial Real Estate Corp. has moved from very attractive to risky, indicating a significant deterioration in its investment appeal. The company appears to be overvalued, particularly given its Price to Book Value of 0.49 and an EV to EBITDA ratio of 1.49, which are not compelling compared to its peers. Additionally, the company has a negative ROE of -2.46%, further highlighting its financial struggles.<BR><BR>In comparison to its peers, TPG RE Finance Trust, Inc. has a more favorable EV to EBITDA of 2.23 and a P/E ratio of 11.75, while Universal Health Realty Income Trust boasts an impressive EV to EBITDA of 7.60 and a P/E of 31.66. The stark contrast in these valuation metrics suggests that Ares Commercial Real Estate Corp. is not only lagging behind its competitors but also facing challenges that could hinder its future performance. Over the past year, Ares has underperformed significantly, with a stock return of -36.95% compared to the S&P 500's 17.14%, reinforcing the notion that it is currently overvalued.

Read More

Is Ares Commercial Real Estate Corp. technically bullish or bearish?

20-Sep-2025

As of September 8, 2025, Ares Commercial Real Estate Corp. is in a mildly bearish trend, with daily indicators signaling bearishness despite some weekly indicators showing mild bullishness, and it has significantly underperformed the S&P 500 with a year-to-date return of -18.00% compared to the index's 12.22%.

As of 8 September 2025, the technical trend for Ares Commercial Real Estate Corp. has changed from sideways to mildly bearish. The current stance is bearish, with key indicators such as the daily moving averages and KST showing mildly bearish signals. While the weekly MACD and Dow Theory are mildly bullish, they are overshadowed by the overall bearish sentiment from the daily indicators. The stock has underperformed against the S&P 500 across multiple periods, with a year-to-date return of -18.00% compared to the S&P 500's 12.22%, and a one-year return of -36.95% versus 17.14% for the index.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of -8.13%

 
2

Risky -

3

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Realty

stock-summary
Market cap

USD 271 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1,004.24%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

-3.48%

stock-summary
Price to Book

0.52

Revenue and Profits:
Net Sales:
-4 Million
(Quarterly Results - Jun 2025)
Net Profit:
-11 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
2.59%
0%
2.59%
6 Months
10.04%
0%
10.04%
1 Year
-27.26%
0%
-27.26%
2 Years
-49.95%
0%
-49.95%
3 Years
-57.47%
0%
-57.47%
4 Years
-65.25%
0%
-65.25%
5 Years
-56.54%
0%
-56.54%

Ares Commercial Real Estate Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-8.13%
EBIT Growth (5y)
-13.07%
EBIT to Interest (avg)
1.60
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
2.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
50.05%
ROCE (avg)
21.50%
ROE (avg)
3.87%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.49
EV to EBIT
1.61
EV to EBITDA
1.49
EV to Capital Employed
0.33
EV to Sales
1.09
PEG Ratio
NA
Dividend Yield
1544.15%
ROCE (Latest)
20.18%
ROE (Latest)
-2.46%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 32 Schemes (24.52%)

Foreign Institutions

Held by 43 Foreign Institutions (3.47%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -112.99% vs 37.34% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -218.28% vs 186.92% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "-4.30",
          "val2": "33.10",
          "chgp": "-112.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-12.80",
          "val2": "24.60",
          "chgp": "-152.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "16.10",
          "val2": "18.20",
          "chgp": "-11.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-11.00",
          "val2": "9.30",
          "chgp": "-218.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "839.40%",
          "chgp": "-83.94%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -52.11% vs 11.17% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 10.03% vs -230.54% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "92.00",
          "val2": "192.10",
          "chgp": "-52.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "60.50",
          "val2": "163.90",
          "chgp": "-63.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "106.00",
          "val2": "109.70",
          "chgp": "-3.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-35.00",
          "val2": "-38.90",
          "chgp": "10.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "795.90%",
          "val2": "368.30%",
          "chgp": "42.76%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
-4.30
33.10
-112.99%
Operating Profit (PBDIT) excl Other Income
-12.80
24.60
-152.03%
Interest
16.10
18.20
-11.54%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-11.00
9.30
-218.28%
Operating Profit Margin (Excl OI)
0.00%
839.40%
-83.94%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is -112.99% vs 37.34% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -218.28% vs 186.92% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
92.00
192.10
-52.11%
Operating Profit (PBDIT) excl Other Income
60.50
163.90
-63.09%
Interest
106.00
109.70
-3.37%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-35.00
-38.90
10.03%
Operating Profit Margin (Excl OI)
795.90%
368.30%
42.76%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -52.11% vs 11.17% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 10.03% vs -230.54% in Dec 2023

stock-summaryCompany CV
About Ares Commercial Real Estate Corp. stock-summary
stock-summary
Ares Commercial Real Estate Corp.
Realty
Ares Commercial Real Estate Corporation is a specialty finance company. The Company is primarily engaged in originating and investing in commercial real estate (CRE) loans and related investments. The Company operates through principal lending segment. Its target investments include senior mortgage loans, subordinated debt, preferred equity, mezzanine loans and other CRE investment opportunities, including commercial mortgage-backed securities. These investments are generally held for investment and are secured, directly or indirectly, by office, multifamily, retail, industrial, lodging, senior-living, self-storage and other commercial real estate properties, or by ownership interests therein. Through the Company's manager, Ares Commercial Real Estate Management LLC, it has investment professionals located across the United States and Europe who directly source loan opportunities for the Company with owners, operators and sponsors of CRE properties.
Company Coordinates stock-summary
Company Details
245 Park Ave Fl 42 , NEW YORK NY : 10167-0002
stock-summary
Tel: 1 212 5153400
stock-summary
Registrar Details